Señales en vivo de 6609.HK | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 abr 2024 @ 03:52):

Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices worldwide...

Stats
Volumen de hoy	500.00
Volumen promedio	65 259.00
Capitalización de mercado	669.00M
EPS	HKD0 ( 2024-03-28 )
Próxima fecha de ganancias	( HKD0 ) 2024-05-20
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	-6.58
ATR14	HKD0.158 (0.88%)

Volumen Correlación

Largo: -0.17 (neutral)

Corto: 0.25 (neutral)

Signal:(37.393) Neutral

Shanghai HeartCare Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Shanghai HeartCare Correlación - Moneda/Commodity

0.76
( moderate )

0.82
( strong )

0.55
( weak )

0.69
( moderate )

-0.83
( strong negative )

-0.28
( neutral )

Shanghai HeartCare Finanzas

Annual	2023
Ingresos:	HKD232.34M
Beneficio Bruto:	HKD163.76M (70.48 %)
EPS:	HKD-2.47

FY	2023
Ingresos:	HKD232.34M
Beneficio Bruto:	HKD163.76M (70.48 %)
EPS:	HKD-2.47

FY	2022
Ingresos:	HKD183.03M
Beneficio Bruto:	HKD124.33M (67.93 %)
EPS:	HKD-5.24

FY	2021
Ingresos:	HKD90.09M
Beneficio Bruto:	HKD54.95M (61.00 %)
EPS:	HKD-6.18

Financial Reports:

No articles found.

Shanghai HeartCare

Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices worldwide. The company offers ischemic stroke thrombectomy, intracranial stenosis treatment, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access devices. Its products are used for the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis, as well as for the treatment of hemorrhagic stroke. The company was formerly known as Shanghai Care Medical Technology Corporation Limited. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.